Return On Equity of Lantern Pharma Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lantern Pharma Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Lantern Pharma Inc. Return On Equity for the quarter ending 30 Sep 2025 was -126%, a 121% decline year-over-year.
  • Lantern Pharma Inc. annual Return On Equity for 2024 was -73%, a 113% decline from 2023.
  • Lantern Pharma Inc. annual Return On Equity for 2023 was -34%, a 44% decline from 2022.
  • Lantern Pharma Inc. annual Return On Equity for 2022 was -24%, a 47% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Lantern Pharma Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -126% -69% -121% 01 Jul 2025 30 Sep 2025
Q2 2025 -100% -53% -115% 01 Apr 2025 30 Jun 2025
Q1 2025 -83% -42% -102% 01 Jan 2025 31 Mar 2025
Q4 2024 -73% -38% -113% 01 Oct 2024 31 Dec 2024
Q3 2024 -57% -27% -90% 01 Jul 2024 30 Sep 2024
Q2 2024 -46% -20% -76% 01 Apr 2024 30 Jun 2024
Q1 2024 -41% -17% -68% 01 Jan 2024 31 Mar 2024
Q4 2023 -34% -10% -44% 01 Oct 2023 31 Dec 2023
Q3 2023 -30% -7.5% -34% 01 Jul 2023 30 Sep 2023
Q2 2023 -26% -2.7% -12% 01 Apr 2023 30 Jun 2023
Q1 2023 -24% -5.3% -28% 01 Jan 2023 31 Mar 2023
Q4 2022 -24% -7.6% -47% 01 Oct 2022 31 Dec 2022
Q3 2022 -22% -4.2% -23% 01 Jul 2022 30 Sep 2022
Q2 2022 -24% -5.2% -28% 01 Apr 2022 30 Jun 2022
Q1 2022 -19% +2.4% +11% 01 Jan 2022 31 Mar 2022
Q4 2021 -16% +20% +56% 01 Oct 2021 31 Dec 2021
Q3 2021 -18% 01 Jul 2021 30 Sep 2021
Q2 2021 -18% 01 Apr 2021 30 Jun 2021
Q1 2021 -22% 01 Jan 2021 31 Mar 2021
Q4 2020 -36% 01 Oct 2020 31 Dec 2020

Lantern Pharma Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -73% -38% -113% 01 Jan 2024 31 Dec 2024
2023 -34% -10% -44% 01 Jan 2023 31 Dec 2023
2022 -24% -7.6% -47% 01 Jan 2022 31 Dec 2022
2021 -16% +20% +56% 01 Jan 2021 31 Dec 2021
2020 -36% +145% +80% 01 Jan 2020 31 Dec 2020
2019 -181% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.